The Cleerly Polygenic Cardiovascular Risk Score Test, powered by Allelica’s proprietary multi-ancestry PRS technology, gives physicians a new option to identify and evaluate patients with an inherited predisposition to coronary plaque.
The Cleerly Polygenic Cardiovascular Risk Score Test, powered by Allelica’s proprietary multi-ancestry PRS technology, gives physicians a new option to identify and evaluate patients with an inherited predisposition to coronary plaque.
First and only biomarker to measure coronary inflammation and assess cardiovascular mortality risk, enabling personalized disease management. CaRi-Heart Risk score identifies cardiovascular risk 10 years in advance.
First and only biomarker to measure coronary inflammation and assess cardiovascular mortality risk, enabling personalized disease management. CaRi-Heart Risk score identifies cardiovascular risk 10 years in advance.
Implicity’s newly cleared ILR ECG algorithm can now analyze data from ICMs across all major device manufacturers, including Abbott, Biotronik, Boston Scientific, and Medtronic.
Implicity’s newly cleared ILR ECG algorithm can now analyze data from ICMs across all major device manufacturers, including Abbott, Biotronik, Boston Scientific, and Medtronic.
ALAMEDA, Calif. – Penumbra, Inc. announced the results of THUNDER, an Investigational Device Exemption (IDE) study, to evaluate the safety and effectiveness of THUNDERBOLT™, the company’s novel...
ALAMEDA, Calif. – Penumbra, Inc. announced the results of THUNDER, an Investigational Device Exemption (IDE) study, to evaluate the safety and effectiveness of THUNDERBOLT™, the company’s novel...
Researchers at the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) have developed an artificial intelligence tool that may help predict serious cardiovascular problems many years before symptoms appear.
The system, known as...
Researchers at the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) have developed an artificial intelligence tool that may help predict serious cardiovascular problems many years before symptoms appear.
The system, known as...
WASHINGTON —The American College of Cardiology (ACC) is introducing a new cardiogenic shock designation to improve outcomes for one of the most life-threatening complications of a heart attack. The new designation builds on the success of the...
WASHINGTON —The American College of Cardiology (ACC) is introducing a new cardiogenic shock designation to improve outcomes for one of the most life-threatening complications of a heart attack. The new designation builds on the success of the...
At week 24 in the CORALreef Lipids and CORALreef HeFH trials, Merck's LIPFENDRA significantly reduced LDL-C by a placebo-adjusted 56% and 59%, respectively.
At week 24 in the CORALreef Lipids and CORALreef HeFH trials, Merck's LIPFENDRA significantly reduced LDL-C by a placebo-adjusted 56% and 59%, respectively.
Serotonin is usually associated with mood, sleep, and digestion. But research published in 2023 suggests this chemical messenger may also influence a small structure that performs a vital job during every heartbeat: the mitral valve.
The...
Serotonin is usually associated with mood, sleep, and digestion. But research published in 2023 suggests this chemical messenger may also influence a small structure that performs a vital job during every heartbeat: the mitral valve.
The...
Given the availability of safer technologies, the authors say broader implementation of enhanced radiation protection devices (ERPDs) is both an ethical responsibility and a necessary evolution of ALARA (“As Low As Reasonably Achievable”),...
Given the availability of safer technologies, the authors say broader implementation of enhanced radiation protection devices (ERPDs) is both an ethical responsibility and a necessary evolution of ALARA (“As Low As Reasonably Achievable”),...
Christopher Iskander, MD, MPH; Mehmet Kucuk, MD; Anne Taylor, MD; Ryan Leahy, MD, MA; Jenny E. Zablah, MD; Gareth J. Morgan, MB, BaO, BCh, MPhil
This case series details the authors' experience with the US Food and Drug Administration's emergency use authorization pathway to obtain the Occlutech Atrial Flow Regulator (Occlutech International AB) for critically ill pediatric patients...
This case series details the authors' experience with the US Food and Drug Administration's emergency use authorization pathway to obtain the Occlutech Atrial Flow Regulator (Occlutech International AB) for critically ill pediatric patients...
Katherine Rand, MD; Roberto Valdovinos, MD; Cynthia Herrington, MD; Neil D. Patel, MD
A 12-year-old boy underwent a chest computed tomography scan for evaluation of hemoptysis and weight loss, which identified multiple pulmonary artery aneurysms (PAAs) including a large left lower-lobe PAA. Infectious workup was negative, and...
A 12-year-old boy underwent a chest computed tomography scan for evaluation of hemoptysis and weight loss, which identified multiple pulmonary artery aneurysms (PAAs) including a large left lower-lobe PAA. Infectious workup was negative, and...
Madjid Boukantar, MD; Oueies Labidi, MD; Patrick Zamora, MD; Romain Gallet, MD, PhD; Tony Truong, MD; Nicolas Lellouche, MD, PhD; Nadia Oubaya, MD; Pierre Andre Natella, MD; Philippe Le Corvoisier, MD; Paul Mathieu Chiaroni, MD; Emmanuel Teiger, MD, PhD
The SXS-CTO trial was designed to compare the incidence of stent malapposition between self-expanding drug-eluting stents (DES) (STENTYS Xposition S [STENTYS S.A]) and balloon-expandable DES in patients undergoing chronic total occlusion...
The SXS-CTO trial was designed to compare the incidence of stent malapposition between self-expanding drug-eluting stents (DES) (STENTYS Xposition S [STENTYS S.A]) and balloon-expandable DES in patients undergoing chronic total occlusion...
A 14-year-old boy with a history of Kawasaki disease diagnosed when he was 4 years old presented for a routine cardiovascular follow-up. He had received intravenous immunoglobulin on the seventh day of his illness and remained on aspirin,...
A 14-year-old boy with a history of Kawasaki disease diagnosed when he was 4 years old presented for a routine cardiovascular follow-up. He had received intravenous immunoglobulin on the seventh day of his illness and remained on aspirin,...
Ioannis Skalidis, MD, PhD; Lisa Simioni, MD; Giulia S. Beretta, MD; Stéphane Cook, MD; Mario Togni, MD; Peter Wenaweser, MD; Julius Jelisejevas, MD; Giacomo Maria Cioffi, MD; Pascal Meier, MD; Michaella Alexandrou, MD; Anastasios Apostolos, MD, PhD; Vasileios Panoulas, MD, PhD; Neila Sayah, MD; Antoinette Neylon, MD; Philippe Garot, MD; Thomas Hovasse, MD; Nicolas Amabile, MD, PhD; Stephane Noble, MD; Mariama Akodad, MD, PhD
The study evaluated the diagnostic performance of angiography-derived, wire-free coronary physiology for detecting fractional flow reserve (FFR)-defined significant stenoses in TAVI candidates and assessed whether accuracy differed when...
The study evaluated the diagnostic performance of angiography-derived, wire-free coronary physiology for detecting fractional flow reserve (FFR)-defined significant stenoses in TAVI candidates and assessed whether accuracy differed when...
A 72-year-old woman with a recent history of stent implantation in the left anterior descending and circumflex arteries, as well as a known inferior left ventricular aneurysm secondary to previous myocardial infarction, presented with...
A 72-year-old woman with a recent history of stent implantation in the left anterior descending and circumflex arteries, as well as a known inferior left ventricular aneurysm secondary to previous myocardial infarction, presented with...
Pradyumna Agasthi, MD; Kaitlyn Krebushevski, MD; Allison K. Cabalka, MD; Jason H. Anderson, MD
A 34-year-old woman with truncus arteriosus type A3 status post 4 prior sternotomies and failed unifocalization presented with severe stenosis of a heavily calcified 22-mm Contegra right ventricle-to-right pulmonary artery conduit...
A 34-year-old woman with truncus arteriosus type A3 status post 4 prior sternotomies and failed unifocalization presented with severe stenosis of a heavily calcified 22-mm Contegra right ventricle-to-right pulmonary artery conduit...
Karthik Murugiah, MBBS, MHS; Mitsuaki Sawano, MD, PhD; Chenxi Huang, PhD; Mariyam Rafla Hassan, MBBS; Daniel Chamié, MD, PhD; Jeptha P. Curtis, MD; Harlan M. Krumholz, MD, SM
Using Medicare Provider Utilization and Payment data, the authors compared intravascular imaging use by operators who performed percutaneous coronary interventions in 2019 to that in 2023.
Using Medicare Provider Utilization and Payment data, the authors compared intravascular imaging use by operators who performed percutaneous coronary interventions in 2019 to that in 2023.